Massive lung collapse with partial resolution after several years: a case report

Elke Govaere1, Dirk Van Raemdonck, Hugo Devlieger

  • 1Dept of Pediatrics, University Hospital of Leuven, Herestraat 49, 3000 Leuven, Belgium. Elke.Govaere@olvz-aalst.be

BMC Pediatrics
|October 26, 2005
PubMed

Insights

Bronchitis obliterans, a rare lung complication in children, can be treated conservatively. This approach may lead to partial lung re-expansion, suggesting surgery as a last resort.

Area of Science:

  • Pediatric Pulmonology
  • Critical Care Medicine

Background:

  • Bronchitis obliterans is a severe complication of pediatric respiratory infections.
  • It leads to significant lung collapse (atelectasis).
  • Historically, surgical lung resection was the standard treatment for survivors.

Observation:

  • A case of infant bronchitis obliterans treated conservatively is presented.
  • The infant underwent non-surgical management for the condition.

Findings:

  • Partial lung re-expansion was observed 5 years post-initial event.
  • Conservative management demonstrated potential for lung recovery.

Implications:

  • This case supports conservative treatment for pediatric bronchitis obliterans.
  • Pneumonectomy (lung removal) should be considered only when other options fail.
Abstract

Related Concept Videos

Atelectasis II: Pathophysiology01:10

Atelectasis II: Pathophysiology

Atelectasis develops when alveoli lose their air and collapse inward. Because lung tissue is naturally elastic, these air sacs shrink rather than remaining open. Collapsed alveoli are no longer ventilated, reducing their role in gas exchange. Blood flow may continue in these regions, creating a ventilation–perfusion mismatch. Clinical findings include decreased breath sounds, dullness to percussion, reduced chest expansion, and decreased tactile fremitus as sound transmission through collapsed...
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Pneumothorax-I01:26

Pneumothorax-I

A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pneumothorax II: Pathophysiology01:08

Pneumothorax II: Pathophysiology

Pneumothorax means the presence of air in the pleural space — the thin potential gap between the visceral and parietal pleura. This condition disrupts the normal pressure balance that keeps the lungs inflated, leading to partial or complete collapse of the affected lung.Normal physiologyUnder normal conditions, the pleural space maintains a slightly negative intrapleural pressure, which keeps the lungs expanded against the chest wall. This negative pressure creates a delicate balance between...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...